Jing Gu

Title: Jing Gu: Innovator in Protein-Protein Interaction Inhibitors

Introduction

Jing Gu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors that target protein-protein interactions. His work is crucial for advancing treatments for various diseases, including leukemia.

Latest Patents

Jing Gu holds a patent for an "Aniline-based WDR5 protein-protein interaction inhibitor, and preparation method and use thereof." This patent describes a WDR5 protein-protein interaction inhibitor, which includes a compound represented by a specific structural formula. Experimental results indicate that this inhibitor selectively inhibits the proliferation of leukemia cells by acting on the WDR5 protein and its interacting proteins, such as MLL. Additionally, it inhibits the methylation of H3K4 and the expression of downstream Hox/Meis-1 genes at the cellular level. The patent also outlines a method for preparing the inhibitor and its potential use in developing drugs for treating acute leukemia and related diseases.

Career Highlights

Jing Gu is affiliated with China Pharmaceutical University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on cancer treatment and drug development.

Collaborations

Jing Gu collaborates with esteemed colleagues, including Qidong You and Xiaoke Guo, who contribute to his research endeavors.

Conclusion

Jing Gu's innovative work in developing protein-protein interaction inhibitors represents a significant advancement in the field of biochemistry. His contributions are vital for the future of targeted cancer therapies.